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Background: One of the most common gold standards for the treatment of Charcot neuroarthropathy (CN)
in the early Eichenholtz stages I and II is immobilization with the total contact casting and lower limb
offloading. However, the total amount of offloading is still debatable.
Objectives: This study evaluates the clinical and radiographic findings in the treatment of early stages of CN
(Eichenholtz stages I and II) with a walker boot and immediate total weight-bearing status.
Methods: Twenty-two patients with type 2 diabetes mellitus (DM) and CN of Eichenholtz stages I and II were
selected for non-operative treatment. All patients were educated about their condition, and full weight
bearing was allowed as tolerated. Patients were monitored on a fortnightly basis in the earlier stages,
with clinical examination, temperature measurement, and standardized weight-bearing radiographs. Their
American Orthopedic Foot and Ankle Society (AOFAS) scores were determined before and after the
treatment protocol.
Results: No cutaneous ulcerations or infections were observed in the evaluated cases. The mean measured
angles at the beginning and end of the study, although showing relative increase, did not present a statistically
significant difference (p 0.05). Mean AOFAS scores showed a statistically significant improvement by the
end of the study (pB0.005).
Conclusion: The treatment of early stages of CN (Eichenholtz stages I and II) with emphasis on walker boot
and immediate weight bearing has shown a good functional outcome, non-progressive deformity on
radiographic assessment, and promising results as a safe treatment option.
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C
harcot neuroarthropathy (CN) is a chronic joint
degeneration involving mainly the foot and ankle.
It is associated with a myriad of conditions that
cause loss of protective sensation in the lower extremities,
such as tabes dorsalis, syringomyelia, Hansen’s disease,
congenital insensitivity to pain, and alcoholism. Today,
diabetes mellitus (DM) is known to be the principal
etiology. CN leads to progressive degeneration of affected
joints and many authors consider it as the main
complication of DM (14). Its prevalence in specialized
services varies from 1 to 13%, and it is found to be 7.5%
in patients with DM. It is bilateral in 10% of cases and
in 60% the affected joint is the tarso-metatarsal, in 30%
the Chopart’s joint, and in 9% the tibiotarsal. Around
5% of the CN cases will have a recurrence, its character-
istics are similar between both genders, and it is most
commonly found in the first decade of DM (1, 36). The
exact pathophysiology of CN joint degeneration remains
under investigation, but present knowledge shows that
sensory neuropathy allowing repeated microtraumas and
(page number not for citation purpose)
  CLINICAL RESEARCH ARTICLE
Diabetic Foot & Ankle 2013. # 2013 Maria C. R. Parisi et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution-
Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction
in any medium, provided the original work is properly cited.
1
Citation: Diabetic Foot & Ankle 2013, 4: 22487 - http://dx.doi.org/10.3402/dfa.v4i0.22487autonomic neuropathy, associated with biological imbal-
ance between osteoblasts and osteoclasts, lead to bone
and joint destruction (69).
CN can be classified according to its clinical outcome
and natural history. One of the most common utilized
systems is the Eichenholtz (10) which divides the condi-
tion into three stages:
Eichenholtz I  stage of development, which is
distinguished by clinical signs and symptoms of inflam-
mation (warmth, erythema, and edema) and the visibility
of radiographic changes. Common radiographic findings
include bone debris formation at the articular margins,
fragmentation of the subchondral bone, subluxation,
dislocation, and capsular distention.
(1) Eichenholtz II  stage of coalescence, is marked by
decreased warmth, erythema, and edema. Radio-
graphs show absorption of fine debris and fusion of
large fragments to adjacent bones. The bone ends
become sclerotic. At this point, the deformity ceases
to progress and transitions to the reconstructive or
remodeling stage.
(2) Eichenholtz III  stage of reconstruction or remo-
deling, is characterized by rounding of the bone ends
with a decrease in sclerosis, leading to consolidation.
A structural bone deformity may be present and this
resultant deformity may lead to skin breakdown and
potential infection followed by amputation.
The usual treatment in Eichenholtz stage I and initial
stage II is immobilization with the total contact casting
and lower limb offloading. Immobilization should remain
until the patient reaches Eichenholtz’s stage III (healing).
However, the time of offloading is debatable with some
authors describing it up to 12 weeks (4, 11, 12). The main
justification for this is that the affected foot is to be
protected from further trauma exerted by the weight-
bearing load, which would contribute to the destructive
inflammatory process of the joint (4, 1315). Surgical
indications for CN reconstruction include structural
deformities at risk for ulceration, significant instability,
recurrent ulcerations, and localized infection (1, 16).
Studies of initial weight bearing in CN have been
recently reported in the literature. Pinzur et al. (17)
studied nine patients with diabetes and acute-phase CN,
Eichenholtz stages I and II, using the total contact
cast and weight bearing, with evaluation every 2 weeks,
yielding promising results. At the end of the study, there
was no anatomical difference between initial and final
evaluations, and the subjects were able to use customized
shoes. Using the same approach with longer follow-up,
Souza, 2 years later, showed similar results (18).
As described, compliance with offloading prescrip-
tion is poor (18), and the objective of this study was
to evaluate the clinical and radiographic findings in the
treatment of Eichenholtz stages I and II with the
walker boot and immediate total weight bearing. In this
study, we prescribed a walker boot  Robofoot (Salvape ´
Produtos Ortope ´dicos, Sa ˜o Paulo, Brazil)  for immobi-
lization of patients with CN, instead of the total contact
cast.
Methods
After approval from the Scientific Commission Univer-
sity, 22 patients with type 2 DM and Eichenholtz stages
I and II CN diagnosis were selected and submitted to
the treatment protocol by the diabetic foot unit from
January 2004 to January 2009. The inclusion and ex-
clusion criteria were determined as shown below.
Inclusion criteria
(1) Patient with type 2 diabetes by the American
Diabetes Association criteria (19);
(2) CN Eichenholtz stages I and II without previous
treatment;
(3) Abnormalities in the neuropathy evaluation, per-
formed with the 5.07/10 g Semmes-Weinstein mono-
filament (Sorry, Bauru, Brazil) and 128-Hz tuning
fork (P. H. Industries Small Industries, Pakistan);
(4) Endocrinological follow-up and glycemic control at
the Sa ˜o Paulo University (Sa ˜o Paulo, Brazil);
(5) Compliance with the proposed treatment protocol;
(6) Regular follow-up with the institution’s social
services.
Exclusion criteria
(1) Presence of plantar foot ulcer at initial evaluation;
(2) Preceding surgical procedure on affected foot;
(3) Preceding osteomyelitis;
(4) Presence of rheumatological and immunological
diseases or alcoholism;
(5) Patient on hemodialysis;
(6) Contralateral limb amputation;
(7) Pregnancy;
(8) Cognitive impairment that would hinder compre-
hension of orientations and medical prescriptions.
Treatment protocol
After clinical and radiographic diagnosis, based on the
criteria described in Table 1, all patients agreed with the
treatment conditions without any other medical imag-
ing studies and their American Orthopedic Foot and
Ankle Society (AOFAS) (20) scores were determined.
The patients received awalker boot  Robofoot†  on the
day of initial evaluation, as well as instructions for the
adequate utilization of the equipment. Specific orienta-
tions about the clinical situation of CN, risks and
implications, and compliance necessity, were given, as
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patients were told to bear weight respecting symptomatic
limitations of each case.
Subjects were monitored every 15 days during the first
12 weeks and monthly thereafter. In all evaluations, a
thorough clinical examination was performed, including
local temperature, skin abnormalities, and standardized
radiographic evaluations. The walker boot was discon-
tinued when patients had shown all three parameters
(clinical, radiographic, and temperature measurement of
comparative lower limbs) as described below:
(1) Clinical: no pain, warmth, erythema, or edema.
(2) Temperature: when the temperature difference be-
tween lower extremities had dropped to less than
28C (21).
(3) Radiographic: bones with a decrease in sclerosis and
signals of consolidation.
The mean time of treatment of the studied population
was 18 weeks. Anteroposterior and lateral foot radio-
graphs in weight-bearing position were performed at the
beginning of the treatment, at 6 weeks, and at the end of
treatment. The radiographic evaluation of the osseous
anatomic pattern and progression, as well as the forefoot
abduction and decrease of the medial longitudinal arch
was made through the measurement of the angle between
the talus and first metatarsal on the lateral radiograph
using a simple goniometer. Its assessment was performed
by two different evaluators. The agreements between the
intraobserver and interobserver were demonstrated high
for images evaluated (k 0.984/k 0.981).
The clinical evolution of the foot and ankle was studied
by using the American Orthopedic Foot and Ankle
Society Ankle-Hindfoot Scale (20) which was applied at
the beginning and end of the study. All patients studied
were under clinical follow-up until the end of this study
(Fig. 1).
Statistical analysis of the results was made by using the
Statistical Analysis System (SAS Institute Inc., 1985) and
Student’s t-test was used to compare parametrical data.
The significance level was settled at pB0.05.
Results
All patients from the studied data had type 2 diabetes;
7 were males and 15 were females, mean age was 56 years
(4764), mean time since DM diagnosis was 13 years
(825), and mean body mass index was 28 (2334) as
shown in Table 2.
Vascular characteristics such as hyperemia, edema,
and comparative temperature, showed improvement by
the end of treatment and there was no change in the pulse
pattern. Cutaneous dehydration resolved when positive
at the beginning of treatment and clawing of the digital
deformities was unaltered until the end of the study.
Cutaneous ulcerations and infections were not observed
in the evaluated cases. There was hyperkeratosis improve-
ment in all patients. Clinical characteristics and mean
AOFAS score are described in Table 3. Mean AOFAS
scores showed a statistically significant improvement by
the end of the study (pB0.005). The mean measured
talar-first metatarsal angle at the beginning and end of
the study, although showing relative increase, did not
present a statistically significant difference (p 0.05) as
shown in Table 4.
Discussion
The pathophysiology of CN still remains under investiga-
tion and the best treatment option is still a matter of
debate. The clinical characteristics of our population were
Table 1. Clinical and radiographic parameters evaluated
Vascular Neuropathy Osteoarticular Cutaneous Radiographic
Pulses (tibial and pedal) Pain Equinus of the foot Ulcer Joint congruence
Hyperemia Proprioception Clawed toes Hyperkeratosis Bone destruction
Edema Dehydration Instability Infection Talar-first metatarsal angle
Comparative temperature Flatfoot
Fig. 1. Clinical and radiographic views of left foot of patient number 5, at the beginning (A, B, C) and end of treatment (DG). (A)
Dorsal foot view, (B) plantar foot view, (C) weight-bearing foot lateral radiograph, (D) walker boot, (E) dorsal foot view, (F) plantar
foot view and (G) weight-bearing foot lateral radiograph.
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affected joint anatomy (tarso-metatarsal joint) but also
the age and time since diagnosis (2224). Many studies
recommended the use of total contact casting and no
weight bearing on the affected CN limb as the initial
therapy of choice to avoid cutaneous complications,
joint instability, and large bone deformities, and also
provide symptomatic relief (13, 2529). However, prac-
tical difficulties in limb offloading and non-compliance
were identified in some studies and also in this study
which were mainly attributed to patient adaptation to the
use of orthosis, diminished proprioception and equili-
brium, locomotion difficulties, need to maintain labor
activities, and large number of medical appointments
(18, 2729).
Studies (17, 18) designed to assess treatment safety
in these patients, when involving precocious weight
bearing in Eichenholtz stages I and II, showed low rates
of complications, which encouraged the start of the
non-surgical, aggressive treatment protocol for diabetic
patients in our institution. Despite our limited selected
group, precise parameters of follow-up, and treatment
protocol safety; limitations of the present study could
best be addressed by a research case series design that
could have affected the internal validity and general-
ization of clinical outcomes.
The multidisciplinary team approach in our institu-
tion, systematic patient follow-up, emergency medical
Table 2. Clinical and demographic values
Patients Gender Age
Time of
diabetes (years)
Body index
mass
1 F 54 15 28
2 F 56 20 31
3 F 62 14 26
4 M 64 18 25
5 F 50 12 27
6 F 48 18 24
7 M 47 14 26
8 F 62 18 27
9 F 60 16 29
10 F 50 25 34
11 F 60 9 23
12 M 49 8 31
13 M 51 14 26
14 F 52 9 28
15 F 54 10 33
16 F 50 15 27
17 F 64 12 25
18 M 61 8 34
19 M 61 11 31
20 M 64 12 28
21 F 53 8 28
22 F 62 10 26
F, female; M, male.
Table 3. Clinical ﬁndings and mean AOFAS score
Beginning of
treatment
End of
treatment
Pulses (tibial and pedal) Present Present
Hyperemia 20 present/2 absent 22 absent
Edema 22 moderate or severe 22 mild
Comparative
temperature
48 (mean) 18 (mean)
Pain 22 present 22 absent
Dehydration 15/7 absent 22 absent
Clawing of fingers 17/5 absent 17/5 absent
Instability 3/19 absent 22 absent
Flatfoot 16/6 absent 22 present
Forefoot abduction 14/8 absent 22 present
Ulcer 22 absent 22 absent
Hyperkeratosis 16/8 absent 22 absent
Infection 22 absent 22 absent
AOFAS 40,54 75,04
AOFAS, American Orthopedic Foot and Ankle Society.
Table 4. Angle values and AOFAS score
Beginning of treatment End of treatment
Patients Initial angle AOFAS score Final angle AOFAS score
1 1 40 1 80
21 0 4 1 1 0 7 4
3 7 40 8 72
4 8 39 9 76
51 5 3 8 1 7 7 4
61 5 4 0 1 6 7 3
71 0 3 8 1 2 7 5
8 9 40 10 75
9 9 41 9 74
10 11 40 11 76
11 10 42 10 70
12 11 40 11 72
13 9 41 9 76
14 6 44 6 79
15 6 39 7 77
16 3 43 4 78
17 6 40 7 77
18 7 42 8 78
19 9 39 10 73
20 9 41 9 74
21 6 44 5 70
22 7 40 7 78
AOFAS, American Orthopedic Foot and Ankle Society.
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diabetic foot syndrome allowed us to rapidly identify the
clinical presentation of the disease and promptly institute
the proposed treatment. The clinical characteristics
elected for evaluation in this study presented stability or
a trend toward improvement at the end of the study that
was found similarly in other studies (17, 18).
The most worrisome and prevalent complications, such
as ulcerations and infections, were not seen in the studied
group; datathat werereported in previous studies (17, 18).
Theflatfootandabductiondeformitiesaffectedallsubjects
by the end of treatment, although radiographic angle
progression that represents them did not show statistical
difference. This biomechanical behavior represents the
healing phase of CN and does not necessarily indicate
worsening of these patients’ prognosis. The AOFAS score
progress was not only statistically significant, but also
encouraging, reflecting the symptomatic and functional
improvement of all patients subjected to this approach.
Conclusion
The treatment of early stages of CN (Eichenholtz stages
I and II) with emphasis on walker boot and immediate
weight bearing has shown a good functional outcome and
non-progressive deformity on radiographic assessment
and may therefore be a safe treatment option.
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